Association of sleep-disordered breathing and ventricular arrhythmias in patients without heart failure.
نویسندگان
چکیده
The prevalence and characteristics of sleep-disordered breathing (SDB) in patients with ventricular arrhythmias, such as premature ventricular complexes and ventricular tachycardia, are unknown. Therefore, this study was conducted to evaluate the prevalence of SDB in patients with severe ventricular arrhythmias and normal left ventricular (LV) function. Thirty-five patients (63% men, mean age 57.4 +/- 13.8 years) underwent a sleep study. All patients had ventricular tachycardia or frequent premature ventricular complexes (>or=300/hour) and had been referred to the cardiology department for medication, catheter ablation therapy, or the implantation of a cardioverter-defibrillator. Patients with heart failure with LV ejection fractions <50% were excluded; in the remaining patients, the mean LV ejection fraction was 63.9 +/- 8.0%. Twenty-one patients (60%) had SDB with apnea-hypopnea indexes >or=5/hour, and the average apnea-hypopnea index was 22.7 +/- 17.9/hour. Twelve patients (34%) had moderate to severe SDB, with an average apnea-hypopnea index of 33.6 +/- 16.6/hour. Central dominant sleep apnea was evident in 3 patients with SDB. The average age and body mass index were significantly higher in patients with SDB than in those without SDB (age 62.0 +/- 12.8 vs 50.6 +/- 12.7 years, body mass index 26.3 +/- 4.0 vs 21.2 +/- 2.0 kg/m2). In conclusion, this study found a high prevalence of SDB in patients with ventricular arrhythmias and normal LV function.
منابع مشابه
Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk.
BACKGROUND The prevalence and characteristics of sleep-disordered breathing in patients with asymptomatic left ventricular (LV) dysfunction are unknown. Therefore, we evaluated the prevalence of sleep-disordered breathing in patients with LV dysfunction without overt heart failure and tested the hypothesis that sleep-disordered breathing is linked to greater hemodynamic and autonomic impairment...
متن کاملSleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator.
STUDY OBJECTIVES The aim of this study was to examine the influence of sleep-related breathing disorders (SBDs) on the occurrence of ventricular arrhythmias in patients with reduced left ventricular ejection fraction (LVEF), and life-threatening ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator. PATIENTS Thirty-eight patients with LVEF of 36 +/- 13% (mean +/-...
متن کاملEffects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure.
BACKGROUND Patients with heart failure and systolic dysfunction may develop disordered breathing during sleep. Repeated episodes of apnea and hypopnea may result in desaturation and arousals, which could adversely affect left ventricular function. The purpose of this study was to determine the short-term effects of continuous positive airway pressure (CPAP) on sleep-disordered breathing and its...
متن کاملRelationship between sleep disorders and erectile dysfunction, depression and quality of life in male patients with systolic heart failure
Background and Purpose: Identification of the effects of sleep disturbances on the quality of life could result in proper treatment of patients with heart failure. This study aimed to investigate the relationship between sleep disorders and erectile dysfunction, depression and quality of life in male patients with systolic heart failure. Methods: This correlational study was conducted on 100...
متن کاملEffect of Sleep-Disordered Breathing on Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Heart Failure
Heart failure (HF) imposes a major public health burden in the United States with a prevalence of 5.1 million and accounts for >30 billion dollars in total costs each year. Sudden arrhythmic death constitutes an important cause of mortality in patients with HF. In randomized controlled trials, implantable cardioverter-defibrillator (ICD) therapy was associated with a reduction in all-cause mort...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The American journal of cardiology
دوره 101 6 شماره
صفحات -
تاریخ انتشار 2008